Thomas H. Kean
Trade Performance Intelligence
Score: 4/10Performance calculated from trade date to most recent market close. Real-time stock data from Financial Modeling Prep. This is not financial advice.
Stock Price at Trade vs. Today
Real market data showing how each stock moved since the congress member traded it.
Suspicious Timing Detected
2 flagsThese flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
| Type | Ticker | Asset | Amount | Trade Price | Current | Change | Date |
|---|---|---|---|---|---|---|---|
| BUY | $DHR | Danaher Corporation Common Stock | $1K-$15K | — | — | — | Jun 11, 2025 |
| BUY | $PLD | Prologis, Inc. Common Stock | $1K-$15K | — | — | — | Jun 30, 2025 |
| PARTIAL SELL | $SYK | Stryker Corporation Common Stock | $15K-$50K | — | — | — | Jun 26, 2025 |
| SELL | $WCC | WESCO International, Inc. Common Stock | $1K-$15K | — | — | — | Jun 23, 2025 |
Connected Legislative Activity
4 signalsThese bills and contracts share tickers or sectors with this filing's trades.
PRICE Act
The PRICE Act establishes a grant program for manufactured housing community improvements, creating a new funding stream for infrastructure upgrades and resident-controlled entities. This directly increases asset values and operational efficiency for owners and operators of affordable manufactured housing communities. The bipartisan sponsorship indicates a high probability of passage.
CREATE JOBS Act
The CREATE JOBS Act (S.2056) proposes to permanently reinstate 100% bonus depreciation, allowing businesses to immediately deduct the full cost of capital investments. This bill, if enacted, would provide a significant tax incentive for companies across all sectors to increase capital expenditures. The bill is currently in the early stages, having been referred to the Senate Committee on Finance.
Medical Research for Our Troops Act
The 'Medical Research for Our Troops Act' (HR3906) proposes to restore $1.181 billion to the Defense Health Agency for military health R&D. This bill is in the early stages, having been referred to the House Committee on Appropriations on June 11, 2025. Companies with defense contracts in clinical research, medical devices, and pharmaceuticals would benefit if this funding is restored.
Critical Infrastructure Security Act
The Critical Infrastructure Security Act (HR5236) has been introduced in the House, expanding CFIUS review to include critical infrastructure real estate transactions with foreign investment. This increases regulatory scrutiny and potential delays for companies operating in these sectors. While the bill is in early stages, it introduces a new layer of regulatory risk for foreign investment in critical infrastructure.
Live Charts
Other Filings by Thomas H. Kean
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.